SunText Review of Endocrine Care

Short commentary

Adherence to Medical and Dietary Therapy in Type 2 Diabetes Patients

Authors: Wood M, Ebe K and Bando H

DOI: 10.51737/2771-5469.2024.019

Keywords: Japan LCD Promotion Association (JLCDPA); Non-Adherence; Healthcare System; Polypharmacy; Nutrition; Low-carbohydrate diet (LCD)

Case Report

Remarkable Effects for HbA1c and Weight by Twymeeg (imeglimin) and EquMet in Type 2 Diabetes (T2D) Patient

Authors: Ogawa T, Bando H, Iwatsuki N, Okada M and Sakamoto K

DOI: 10.51737/2771-5469.2024.020

Keywords: Imeglimin (Twymeeg); Trials of IMeglimin for Efficacy and Safety (TIMES); vildagliptin/metformin (EquMet); Low Carbohydrate Diet (LCD); Japan LCD promotion association (JLCDPA)

Research Article

Parallel Improvement of HbA1c and Arteriosclerosis during Clinical Progress for Diabetic Patient

Authors: Bando H, Okada M, Iwatsuki N, Ogawa T and Sakamoto K

DOI: 10.51737/2771-5469.2024.021

Keywords: Imeglimin (Twymeeg); Pulse wave velocity (PWV); Cardio-ankle vascular index (CAVI); Japan LCD promotion Association (JLCDPA); Mean amplitude of glucose excursions (MAGE)

Research Article

Significant Effect of Improved Glucose Variability by Standard Low Carbohydrate Diet (LCD) and EquMet

Authors: Bando H, Okada M, Iwatsuki N, Sakamoto K and Ogawa T

DOI: 10.51737/2771-5469.2024.022

Keywords: Metformin/vildagliptin (EquMet); Standard low carbohydrate diet (LCD); Japan LCD promotion Association (JLCDPA); Mean amplitude of glycemic excursions (MAGE); Vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY)

Research Article

Effect of Thyroid Disorder in Pregnant Women Admitted In Tertiary Care Hospital

Authors: Rubi NA, Mirza TT, Iqbal S

DOI: 10.51737/2771-5469.2024.023

Keywords: Thyroid dysfunction; Endocrine disorder; Preterm delivery; Preeclampsia; IUGR

Short commentary

Standards of Care in Diabetes 2025: Diabetes-Associated Autoantibodies

Authors: Michael Wood, Hiroshi Bando and Koji Ebe

DOI: 10.51737/2771-5469.2024.024

Keywords: Type 1 diabetes (T1D); Diabetes-associated autoantibodies (DAA); Screening; Risk; Dysglycemia; American Diabetes Association (ADA); Standards of care (SoC)